Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Timing of Hodgkin lymphoma radiotherapy to women’s first period critical for breast cancer risk
ICR scientists find radiotherapy near a woman's first period increases breast cancer risk, but pregnancy doesn't increase danger.
Longer Lives for Multiple Myeloma Patients
Multiple Myeloma affects around 4000 people each year. The average survival time after diagnosis is just three to five years, so new treatment options are urgently needed
Next-generation “epigenetic” cancer pill shown to be safe
Scientists have shown that a brand new type of cancer pill that exploits the emerging field of epigenetics is safe for human use, according to a Phase I trial reported today in Clinical Cancer Research.
Pill Brings Promise for Patients with Skin Cancer
Strength of early results means all 'placebo arm' trial patients will be offered treatment with RG7204.
Mutation Confirmed as Melanoma Drug Target
A mutation present in around half of malignant melanomas has been confirmed as a strong drug target, according to research published today in Science Translation Medicine.
Genetic Mutation Shown to Trigger Melanoma
Researchers have discovered that a genetic mutation found in some malignant melanomas can initiate development of this most deadly form of skin cancer, according to a study published today in the journal Cancer Research.
Discovery Could Help Refine Advanced Melanoma Treatment
A team of UK scientists has made the unexpected discovery that drugs which target a well known fault in a protein called BRAF could actually fuel the progression of cancer in some cases. The findings of this study, which was jointly funded by Cancer Research UK, The Institute of Cancer Research (ICR) and the Wellcome Trust are published today (Thursday) in Cell*.
Cervical Cancer Risk for Women over 50
Cervical cancer screening for over 50-year-olds continues to find abnormalities even if they have clear results in their 40s, a new study published by The Institute of Cancer Research (ICR) in the British Journal of Cancer has revealed.
New Technique Detects Early Cervical Cancer
The Institute of Cancer Research and The Royal Marsden Hospital have developed a new imaging technique which locates previously undetectable early stage cervical cancers, according to research published in Radiology today (October 21).
Neuroblastoma: Genetic Risks Found
Scientists at The Institute of Cancer Research, led by Professor Nazneen Rahman, have been taking part in an international study into the causes of neuroblastoma, an aggressive childhood cancer. The findings were published this week in the New England Journal of Medicine*.
Faster Chemo Increases Neuroblastoma Survival
Chemotherapy given with shorter intervals between treatments than conventional chemotherapy increases survival rates by two thirds in children with high-risk neuroblastoma, according to a study published in the Lancet Oncology* today (Tuesday).
Leukaemia Stem Cells Found
A breakthrough study of identical twins has for the first time confirmed the existence of cancer stem cells that cause the most common form of childhood cancer, acute lymphoblastic leukaemia (ALL) – backing evidence that this childhood cancer starts in the womb.